SlideShare a Scribd company logo
1 of 1
Download to read offline
The generation of a stable master cell line requires the integration of the expression cassette into
the host cell genome. Strong promoters like the immediate early cytomegalovirus (CMV) or the
cellular elongation factor (EF) 1-alpha promoter and polyadenylation sites from the simian virus (SV)
40 or the bovine growth hormone (BGH) for improved mRNA stability and translation efficiency are
usually implemented into the expression vector. Furthermore, there are different methods to
enhance antibody expression by increasing the number of antibody gene copies in the genome
through gene amplification. The generation of producer cell lines is still a time-consuming, laborious,
and quite expensive process, although the procedure has been dramatically improved and
accelerated. Therefore, transient expression is helpful, especially when a large number of different
antibodies have to be expressed at lower or medium yields or the product homogeneity is not critical,
for example, in research and development. Moreover, transient mammalian antibody production can
be scaled up by employing batch or fed-batch bioreactor processes to more than 150 L production
volumes. Therefore, transient antibody production is suitable for small-scale production in antibody
screening, but also capable to generate grams of antibodies.
Figure.3 Evolution of antibody production yields. (a) Evolution of volumetric productivity of antibody production
processes in mammalian cells. An increase of about 100-fold was achieved in the past 20 years. The values and
ranges shown in the graph are based on personal experience, literature and conference presentations without
claiming completeness. The Y-axis is drawn in logarithmic scale. (b) Evolution of cell specific productivity (qp) of
mammalian antibody producing cell lines. An increase of about tenfold was achieved during the past 20 years. The
values and ranges shown in the graph are based on personal experience, literature and conference presentations
without claiming completeness. The Y-axis is showing productivities in pg per cell and day (pcd) and drawn in
logarithmic scale. (Modified from (Knopf 2008))

More Related Content

What's hot

Strain improvement through genetic engineering
Strain improvement through genetic engineeringStrain improvement through genetic engineering
Strain improvement through genetic engineering
Sulov Saha
 
이연석 EPI Presentation
이연석 EPI Presentation이연석 EPI Presentation
이연석 EPI Presentation
Austin Lee
 

What's hot (16)

High-performing CHO cell lines
High-performing CHO cell lines High-performing CHO cell lines
High-performing CHO cell lines
 
Strain improvement through genetic engineering
Strain improvement through genetic engineeringStrain improvement through genetic engineering
Strain improvement through genetic engineering
 
High yield production of therapeutic proteins in chloroplast
High yield production of therapeutic proteins in chloroplastHigh yield production of therapeutic proteins in chloroplast
High yield production of therapeutic proteins in chloroplast
 
Protein expression and purification services from creative biomart
Protein expression and purification services from creative biomartProtein expression and purification services from creative biomart
Protein expression and purification services from creative biomart
 
Strain improvement studies on L-aspaginase producing bacteria
Strain improvement studies on L-aspaginase producing bacteriaStrain improvement studies on L-aspaginase producing bacteria
Strain improvement studies on L-aspaginase producing bacteria
 
The cell line integrity
The cell line integrityThe cell line integrity
The cell line integrity
 
Industrial production of recombinant therapeutics
Industrial production of recombinant therapeuticsIndustrial production of recombinant therapeutics
Industrial production of recombinant therapeutics
 
Conventional routes of Strain improvement
Conventional routes of Strain improvementConventional routes of Strain improvement
Conventional routes of Strain improvement
 
2014 11 07_pegs_europe_lisbon_ritala
2014 11 07_pegs_europe_lisbon_ritala2014 11 07_pegs_europe_lisbon_ritala
2014 11 07_pegs_europe_lisbon_ritala
 
Ppt.strain improvement by ghalia nawal
Ppt.strain improvement by ghalia nawalPpt.strain improvement by ghalia nawal
Ppt.strain improvement by ghalia nawal
 
Plantibody final
Plantibody finalPlantibody final
Plantibody final
 
Baculovirus expression service
Baculovirus expression serviceBaculovirus expression service
Baculovirus expression service
 
Strain development techniques of industrially important microorganisms
Strain development techniques of industrially important microorganismsStrain development techniques of industrially important microorganisms
Strain development techniques of industrially important microorganisms
 
Bacterial efflux pump inhibitory activity of some indigenous medicinal plants...
Bacterial efflux pump inhibitory activity of some indigenous medicinal plants...Bacterial efflux pump inhibitory activity of some indigenous medicinal plants...
Bacterial efflux pump inhibitory activity of some indigenous medicinal plants...
 
이연석 EPI Presentation
이연석 EPI Presentation이연석 EPI Presentation
이연석 EPI Presentation
 
Strain improvement technique (exam point of view)
Strain improvement technique (exam point of view)Strain improvement technique (exam point of view)
Strain improvement technique (exam point of view)
 

Similar to The generation of a stable master cell line

Molecular characterisation, attenuation and inactivation of very virulent inf...
Molecular characterisation, attenuation and inactivation of very virulent inf...Molecular characterisation, attenuation and inactivation of very virulent inf...
Molecular characterisation, attenuation and inactivation of very virulent inf...
Majed Mohammed
 
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
InsideScientific
 
Nucl. Acids Res.-2013-Sung-e139
Nucl. Acids Res.-2013-Sung-e139Nucl. Acids Res.-2013-Sung-e139
Nucl. Acids Res.-2013-Sung-e139
Alice Lan
 
BIOPHARM_May Article_FINAL eprint
BIOPHARM_May Article_FINAL eprintBIOPHARM_May Article_FINAL eprint
BIOPHARM_May Article_FINAL eprint
Doug Mogensen
 

Similar to The generation of a stable master cell line (20)

Improved vector design eases cell line development workflow in the CHOZN GS-/...
Improved vector design eases cell line development workflow in the CHOZN GS-/...Improved vector design eases cell line development workflow in the CHOZN GS-/...
Improved vector design eases cell line development workflow in the CHOZN GS-/...
 
Reducing time to clinic with CHOvolution™ cell line
Reducing time to clinic with CHOvolution™ cell line Reducing time to clinic with CHOvolution™ cell line
Reducing time to clinic with CHOvolution™ cell line
 
Startvac mechanism of action
Startvac mechanism of action Startvac mechanism of action
Startvac mechanism of action
 
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
 
Muthamilselvan et al-2015-plant_biotechnology_journal
Muthamilselvan et al-2015-plant_biotechnology_journalMuthamilselvan et al-2015-plant_biotechnology_journal
Muthamilselvan et al-2015-plant_biotechnology_journal
 
Molecular characterisation, attenuation and inactivation of very virulent inf...
Molecular characterisation, attenuation and inactivation of very virulent inf...Molecular characterisation, attenuation and inactivation of very virulent inf...
Molecular characterisation, attenuation and inactivation of very virulent inf...
 
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
 
Nucl. Acids Res.-2013-Sung-e139
Nucl. Acids Res.-2013-Sung-e139Nucl. Acids Res.-2013-Sung-e139
Nucl. Acids Res.-2013-Sung-e139
 
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingPlatform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
 
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and ManufacturingPlatform Technologies to Accelerate Novel Vaccine Development and Manufacturing
Platform Technologies to Accelerate Novel Vaccine Development and Manufacturing
 
Antibody avidity
Antibody avidityAntibody avidity
Antibody avidity
 
mRNA Encoded Antibodies
mRNA Encoded AntibodiesmRNA Encoded Antibodies
mRNA Encoded Antibodies
 
Cloning and Expression of recombinant Protein
Cloning and Expression of recombinant ProteinCloning and Expression of recombinant Protein
Cloning and Expression of recombinant Protein
 
BIOPHARM_May Article_FINAL eprint
BIOPHARM_May Article_FINAL eprintBIOPHARM_May Article_FINAL eprint
BIOPHARM_May Article_FINAL eprint
 
Affinity maturation of antibodies
Affinity maturation of antibodiesAffinity maturation of antibodies
Affinity maturation of antibodies
 
Vaccine Production Strategies Who Working Group B
Vaccine Production Strategies  Who Working Group BVaccine Production Strategies  Who Working Group B
Vaccine Production Strategies Who Working Group B
 
Recombinant Antibody Overview II - Creative Biolabs
Recombinant Antibody Overview II - Creative BiolabsRecombinant Antibody Overview II - Creative Biolabs
Recombinant Antibody Overview II - Creative Biolabs
 
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
Thomas Sterovsky - Polymun Scientific (Vienna Conference, April 2016)
 
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
 
OS18 - 9.b.6 The use of reverse genetics to facilitate the growth of FMDV fo...
OS18 - 9.b.6  The use of reverse genetics to facilitate the growth of FMDV fo...OS18 - 9.b.6  The use of reverse genetics to facilitate the growth of FMDV fo...
OS18 - 9.b.6 The use of reverse genetics to facilitate the growth of FMDV fo...
 

More from EchoHan4

More from EchoHan4 (20)

ADC conjugate sites analysis
ADC conjugate sites analysisADC conjugate sites analysis
ADC conjugate sites analysis
 
adc chemistry
adc chemistryadc chemistry
adc chemistry
 
ADC Biotechnology
ADC BiotechnologyADC Biotechnology
ADC Biotechnology
 
Antibody Design and Conjugation
Antibody Design and ConjugationAntibody Design and Conjugation
Antibody Design and Conjugation
 
adc cd40
adc cd40adc cd40
adc cd40
 
adc cd30
adc cd30adc cd30
adc cd30
 
ADC Biochemical Analysis
ADC Biochemical AnalysisADC Biochemical Analysis
ADC Biochemical Analysis
 
ADC Antibody Screening
ADC Antibody ScreeningADC Antibody Screening
ADC Antibody Screening
 
ADC Affinity Measurement
ADC Affinity MeasurementADC Affinity Measurement
ADC Affinity Measurement
 
adc adcc
adc adccadc adcc
adc adcc
 
5t4 adc
5t4 adc5t4 adc
5t4 adc
 
Modality
ModalityModality
Modality
 
IND Publishing and Submission
IND Publishing and SubmissionIND Publishing and Submission
IND Publishing and Submission
 
Pre-IND Meeting
Pre-IND MeetingPre-IND Meeting
Pre-IND Meeting
 
Medical Writing and Translation
Medical Writing and TranslationMedical Writing and Translation
Medical Writing and Translation
 
Regulatory Strategy Consulting
Regulatory Strategy ConsultingRegulatory Strategy Consulting
Regulatory Strategy Consulting
 
IND Regulatory Services
IND Regulatory ServicesIND Regulatory Services
IND Regulatory Services
 
cGMP Manufacturing
cGMP ManufacturingcGMP Manufacturing
cGMP Manufacturing
 
Antibody and Protein Toxicology
Antibody and Protein ToxicologyAntibody and Protein Toxicology
Antibody and Protein Toxicology
 
Antibody and Protein Pharmacology
Antibody and Protein PharmacologyAntibody and Protein Pharmacology
Antibody and Protein Pharmacology
 

Recently uploaded

Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptxNanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
ssusera4ec7b
 
Warming the earth and the atmosphere.pptx
Warming the earth and the atmosphere.pptxWarming the earth and the atmosphere.pptx
Warming the earth and the atmosphere.pptx
GlendelCaroz
 
Heat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree daysHeat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree days
Brahmesh Reddy B R
 

Recently uploaded (20)

GBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationGBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolation
 
MSC IV_Forensic medicine - Mechanical injuries.pdf
MSC IV_Forensic medicine - Mechanical injuries.pdfMSC IV_Forensic medicine - Mechanical injuries.pdf
MSC IV_Forensic medicine - Mechanical injuries.pdf
 
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptxNanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
 
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptxSaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
 
ANATOMY OF DICOT AND MONOCOT LEAVES.pptx
ANATOMY OF DICOT AND MONOCOT LEAVES.pptxANATOMY OF DICOT AND MONOCOT LEAVES.pptx
ANATOMY OF DICOT AND MONOCOT LEAVES.pptx
 
Warming the earth and the atmosphere.pptx
Warming the earth and the atmosphere.pptxWarming the earth and the atmosphere.pptx
Warming the earth and the atmosphere.pptx
 
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
Soil and Water Conservation Engineering (SWCE) is a specialized field of stud...
 
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdfFORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
FORENSIC CHEMISTRY ARSON INVESTIGATION.pdf
 
Factor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandFactor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary Gland
 
EU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdfEU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdf
 
Mining Activity and Investment Opportunity in Myanmar.pptx
Mining Activity and Investment Opportunity in Myanmar.pptxMining Activity and Investment Opportunity in Myanmar.pptx
Mining Activity and Investment Opportunity in Myanmar.pptx
 
GBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) EnzymologyGBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) Enzymology
 
TEST BANK for Organic Chemistry 6th Edition.pdf
TEST BANK for Organic Chemistry 6th Edition.pdfTEST BANK for Organic Chemistry 6th Edition.pdf
TEST BANK for Organic Chemistry 6th Edition.pdf
 
Introduction and significance of Symbiotic algae
Introduction and significance of  Symbiotic algaeIntroduction and significance of  Symbiotic algae
Introduction and significance of Symbiotic algae
 
PHOTOSYNTHETIC BACTERIA (OXYGENIC AND ANOXYGENIC)
PHOTOSYNTHETIC BACTERIA  (OXYGENIC AND ANOXYGENIC)PHOTOSYNTHETIC BACTERIA  (OXYGENIC AND ANOXYGENIC)
PHOTOSYNTHETIC BACTERIA (OXYGENIC AND ANOXYGENIC)
 
GBSN - Microbiology (Unit 4) Concept of Asepsis
GBSN - Microbiology (Unit 4) Concept of AsepsisGBSN - Microbiology (Unit 4) Concept of Asepsis
GBSN - Microbiology (Unit 4) Concept of Asepsis
 
POST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptx
POST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptxPOST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptx
POST TRANSCRIPTIONAL GENE SILENCING-AN INTRODUCTION.pptx
 
NUMERICAL Proof Of TIme Electron Theory.
NUMERICAL Proof Of TIme Electron Theory.NUMERICAL Proof Of TIme Electron Theory.
NUMERICAL Proof Of TIme Electron Theory.
 
Heat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree daysHeat Units in plant physiology and the importance of Growing Degree days
Heat Units in plant physiology and the importance of Growing Degree days
 
Terpineol and it's characterization pptx
Terpineol and it's characterization pptxTerpineol and it's characterization pptx
Terpineol and it's characterization pptx
 

The generation of a stable master cell line

  • 1. The generation of a stable master cell line requires the integration of the expression cassette into the host cell genome. Strong promoters like the immediate early cytomegalovirus (CMV) or the cellular elongation factor (EF) 1-alpha promoter and polyadenylation sites from the simian virus (SV) 40 or the bovine growth hormone (BGH) for improved mRNA stability and translation efficiency are usually implemented into the expression vector. Furthermore, there are different methods to enhance antibody expression by increasing the number of antibody gene copies in the genome through gene amplification. The generation of producer cell lines is still a time-consuming, laborious, and quite expensive process, although the procedure has been dramatically improved and accelerated. Therefore, transient expression is helpful, especially when a large number of different antibodies have to be expressed at lower or medium yields or the product homogeneity is not critical, for example, in research and development. Moreover, transient mammalian antibody production can be scaled up by employing batch or fed-batch bioreactor processes to more than 150 L production volumes. Therefore, transient antibody production is suitable for small-scale production in antibody screening, but also capable to generate grams of antibodies. Figure.3 Evolution of antibody production yields. (a) Evolution of volumetric productivity of antibody production processes in mammalian cells. An increase of about 100-fold was achieved in the past 20 years. The values and ranges shown in the graph are based on personal experience, literature and conference presentations without claiming completeness. The Y-axis is drawn in logarithmic scale. (b) Evolution of cell specific productivity (qp) of mammalian antibody producing cell lines. An increase of about tenfold was achieved during the past 20 years. The values and ranges shown in the graph are based on personal experience, literature and conference presentations without claiming completeness. The Y-axis is showing productivities in pg per cell and day (pcd) and drawn in logarithmic scale. (Modified from (Knopf 2008))